Shares of companies testing Ebola vaccines rise

SHARE Shares of companies testing Ebola vaccines rise

NEW YORK (AP) — Shares of companies that are studying potential vaccines for Ebola are climbing in aftermarket trading after federal officials announced that the first case of the disease has been diagnosed in the U.S.

The Centers for Disease Control says a patient being treated at a hospital in Dallas tested positive for the disease.

Ebola is believed to have sickened more than 6,500 people in West Africa, and more than 3,000 people have died. Symptoms can start as much as 21 days after exposure, and the disease isn’t contagious until symptoms begin. It takes close contact with bodily fluids to spread.

The World Health Organization has worked to speed up the use of some experimental vaccines and companies are ramping up testing.

The Latest
The massive pop culture convention runs through Sunday at McCormick Place.
With all the important priorities the state has to tackle, why should Springfield rush to help the billionaire McCaskey family build a football stadium? The answer: They shouldn’t. The arguments so far don’t convince us this project would truly benefit the public.
Art
“Chryssa & New York” is the first museum show in North America in more than four decades to spotlight the artist. It also highlights her strong ties to Chicago’s art world.
If these plans for new stadiums from the Bears, White Sox and Red Stars are going to have even a remote chance of passage, teams will have to drastically scale back their state asks and show some tangible benefits for state taxpayers.
The Bears put the figure at $4.7 billion. But a state official says the tally to taxpayers goes even higher when you include the cost of refinancing existing debt.